Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3
National · Effective Oct 1, 2026
1 active Medicare policy lists J7183, and 18 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Oct 1, 2026
18 policies from 13 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7183 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Wilate | Sep 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Wilate | Sep 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Wilate | Sep 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Wilate | Sep 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Von Willebrand Factors (Vonvendi [von Willebrand factor {recombinant}], Wilate [von Willebrand factor/coagulation factor VIII complex {human}]) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Von Willebrand Factors (Vonvendi [von Willebrand factor {recombinant}], Wilate [von Willebrand factor/coagulation factor VIII complex {human}])Effective 12/01/2025 - 02/28/2026 | Dec 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Factor VIII (e.g., Advate, Adynovate, Afstyla, Alphanate, Altuviiio, Eloctate, Esperoct, Jivi, Hemofil-M, Humate-P, Koate, Kovaltry, Novoeight, Nuwiq, Obizur, Recombinate, Wilate, Xyntha) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Wilate | Sep 1, 2026 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Factor VIII- von Willebrand (Alphanate, Humate-P, Vonvendi, Wilate); CP.PHAR.216 (PDF | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Hemophilia Products - Factor VIII (Hemophilia A) and Von Willebrand disease (VWD): Alphanate, Humate-P, and Wilate | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Factor VIII/VWF Complex: Alphanate, Humate-P, and Wilate | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7183 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |